Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Open-market sale Director sold 964 shares at $23.89 ($23,033)
  2. 4 Open-market sale Director sold 964 shares at $23.89 ($23,027)
  3. 4 Open-market sale Director sold 964 shares at $23.89 ($23,025)
  4. 4 Grant or award Director acquired 4,053 shares (grant or award)
  5. 4 Open-market sale Chief Operating Officer sold 3,324 shares at an average $16.02 ($53,253)
  6. 4 Open-market sale EVP, Pres., Novocure Oncology sold 2,519 shares at an average $16.02 ($40,358)
  7. 4 Grant or award Chief Financial Officer acquired 102,249 shares (grant or award)
  8. 4 Open-market sale EVP, Pres., Novocure Oncology sold 2,078 shares at $16.14 ($33,545)
  9. 4 Grant or award Chief Human Resources Officer acquired 71,574 shares (grant or award)
  10. 4 Grant or award Chief Innovation Officer acquired 81,799 shares (grant or award)
  11. 4 Grant or award Chief Medical Officer acquired 51,124 shares (grant or award)
  12. 4 Grant or award Chief Science Officer acquired 51,124 shares (grant or award)
  13. 4 Grant or award General Counsel acquired 81,927 shares (grant or award)
  14. 4 Open-market sale Chief Operating Officer sold 2,303 shares at $16.14 ($37,177)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Growth Officer sold 382 shares at $12.65 ($4,832)
  19. 4 Grant or award Chief Human Resources Officer acquired 37,593 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 39 · 780 filings